Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Repta

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacy and Pharmacology|November 1, 1984
Development of an intravenous formulation for the unstable investigational cytotoxic nucleosides 5-azacytosine arabinoside (NSC 281272) and 5-azacytidine (NSC 102816)P Mojaverian, A J Repta
Journal of Pharmaceutical Sciences|February 1, 1989
Buccal drug absorption. II: In vitro diffusion across the hamster cheek pouchK W Garren, A J Repta
Biopharmaceutics & Drug Disposition|January 1, 1981
Cisplatin: chemistry, distribution and biotransformationD F Long, A J Repta
Journal of Pharmaceutical Sciences|June 1, 1981
Oxidative degradation of 6-selenoguanosine in aqueous solutionsA J Repta, Y A Beltagy
Journal of Pharmaceutical Sciences|November 1, 1975
Complexation in formulation of parenteral solutions: solubilization of the cytotoxic agent hexamethylmelamine by complexation with gentisic acid speciesB Kreilgård, T Higuchi, A J Repta
Journal of Pharmaceutical Sciences|October 1, 1980
Antioxidants in purification, stabilization, and formulation of the antineoplastic agent 6-selenoguanosineY A Beltagy, W Waugh, A J Repta
Journal of Pharmaceutical Sciences|May 1, 1977
Acetylacroninium salts as soluble prodrugs of the antineoplastic agent acronineD W Bourne, T Higuchi, A J Repta
Journal of Chromatography|February 13, 1981
Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis((2-[(2-hydroxyethyl)amino]ethyl)-amino)9,10-anthracenedio ne dihydrochloride (NSC 301739) in plasma. Application of temperature control to provide selectivity in paired-ion high-performance liquid chromatographyD L Reynolds, L A Sternson, A J Repta
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1986
Aspects of the stability of isoindoles derived from the reaction of o-phthalaldehyde-ethanethiol with primary amino compoundsJ F Stobaugh, A J Repta, L A Sternson
Journal of Pharmaceutical Sciences|February 1, 1976
Utilization of an enantiomer as a solution to a pharmaceutical problem: application to solubilization of 1,2-di(4-piperazine-2,6-dione)propaneA J Repta, M J Baltezor, P C Bansal
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacy and Pharmacology|November 1, 1984
Development of an intravenous formulation for the unstable investigational cytotoxic nucleosides 5-azacytosine arabinoside (NSC 281272) and 5-azacytidine (NSC 102816)P Mojaverian, A J Repta
Journal of Pharmaceutical Sciences|February 1, 1989
Buccal drug absorption. II: In vitro diffusion across the hamster cheek pouchK W Garren, A J Repta
Biopharmaceutics & Drug Disposition|January 1, 1981
Cisplatin: chemistry, distribution and biotransformationD F Long, A J Repta
Journal of Pharmaceutical Sciences|June 1, 1981
Oxidative degradation of 6-selenoguanosine in aqueous solutionsA J Repta, Y A Beltagy
Journal of Pharmaceutical Sciences|November 1, 1975
Complexation in formulation of parenteral solutions: solubilization of the cytotoxic agent hexamethylmelamine by complexation with gentisic acid speciesB Kreilgård, T Higuchi, A J Repta
Journal of Pharmaceutical Sciences|October 1, 1980
Antioxidants in purification, stabilization, and formulation of the antineoplastic agent 6-selenoguanosineY A Beltagy, W Waugh, A J Repta
Journal of Pharmaceutical Sciences|May 1, 1977
Acetylacroninium salts as soluble prodrugs of the antineoplastic agent acronineD W Bourne, T Higuchi, A J Repta
Journal of Chromatography|February 13, 1981
Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis((2-[(2-hydroxyethyl)amino]ethyl)-amino)9,10-anthracenedio ne dihydrochloride (NSC 301739) in plasma. Application of temperature control to provide selectivity in paired-ion high-performance liquid chromatographyD L Reynolds, L A Sternson, A J Repta
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1986
Aspects of the stability of isoindoles derived from the reaction of o-phthalaldehyde-ethanethiol with primary amino compoundsJ F Stobaugh, A J Repta, L A Sternson
Journal of Pharmaceutical Sciences|February 1, 1976
Utilization of an enantiomer as a solution to a pharmaceutical problem: application to solubilization of 1,2-di(4-piperazine-2,6-dione)propaneA J Repta, M J Baltezor, P C Bansal
Pageof 4